TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiation therapy

被引：0
|
作者：
Gao, Chan [1 ]
机构：
[1] City Hope Natl Canc Inst, Duarte, CA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-C285
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C285
引用
收藏
页数：1
相关论文
共 50 条
  • [41] T granules in human platelets function in TLR9 organization and signaling
    Thon, Jonathan N.
    Peters, Christopher G.
    Machlus, Kellie R.
    Aslam, Rukhsana
    Rowley, Jesse
    Macleod, Hannah
    Devine, Matthew T.
    Fuchs, Tobias A.
    Weyrich, Andrew S.
    Semple, John W.
    Flaumenhaft, Robert
    Italiano, Joseph E., Jr.
    JOURNAL OF CELL BIOLOGY, 2012, 198 (04): : 561 - 574
  • [42] TLR9 signaling in fibroblastic reticular cells regulates peritoneal immunity
    Xu, Li
    Li, Yiming
    Yang, Chenxuan
    Loughran, Patricia
    Liao, Hong
    Hoffman, Rosemary
    Billiar, Timothy R.
    Deng, Meihong
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (09): : 3657 - 3669
  • [43] TLR9 signaling in fibroblastic reticular cells regulates peritoneal immunity
    Xu, L.
    Li, Y.
    Yang, C.
    Loughran, P.
    Billiar, T.
    Deng, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 69 - 69
  • [44] Reciprocal Expression and Signaling of TLR4 and TLR9 in the Pathogenesis and Treatment of Necrotizing Enterocolitis
    Gribar, Steven C.
    Sodhi, Chhinder P.
    Richardson, Ward M.
    Anand, Rahul J.
    Gittes, George K.
    Branca, Maria F.
    Jakub, Adam
    Shi, Xia-hua
    Shah, Sohail
    Ozolek, John A.
    Hackam, David J.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (01): : 636 - 646
  • [45] Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
    Shen, Kuan-Yin
    Liu, Hsin-Yu
    Yan, Wan-Lun
    Wu, Chiao-Chieh
    Lee, Ming-Hui
    Leng, Chih-Hsing
    Liu, Shih-Jen
    CANCERS, 2020, 12 (04)
  • [46] Role of TLR9 in Oncogenic Virus-Produced Cancer
    Martinez-Campos, Cecilia
    Burguete-Garcia, Ana I.
    Madrid-Marina, Vicente
    VIRAL IMMUNOLOGY, 2017, 30 (02) : 98 - 105
  • [47] TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy
    Kang, Tae Heung
    Mao, Chih-Ping
    Kim, Young Seob
    Kim, Tae Woo
    Yang, Andrew
    Lam, Brandon
    Tseng, Ssu-Hsueh
    Farmer, Emily
    Park, Yeong-Min
    Hung, Chien-Fu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [48] Development of an inhaled TLR9 agonist for the immunotherapy of lung cancer
    Gallotta, Marilena
    Assi, Hikmat
    Coffman, Robert L.
    Guiducci, Cristiana
    CANCER RESEARCH, 2017, 77
  • [49] THE MTOR INHIBITOR EVEROLIMUS COOPERATES WITH THE TLR9 AGONIST IMO IN RENAL CELL CARCINOMA BY INTERFERING WITH BOTH TUMOR CELLS AND MICROENVIRONMENT
    Tortora, J. G.
    Rosa, R.
    Bianco, R.
    Gelardi, T.
    Garofalo, S.
    Marciano, R.
    Nappi, L.
    Formisano, L.
    Serpico, D.
    Damiano, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 274 - 274
  • [50] CpG Ofigodeoxynudeofides as TLR9 Agonists Therapeutic Applications in Cancer
    Murad, Yanal M.
    Clay, Timothy M.
    BIODRUGS, 2009, 23 (06) : 361 - 375
12345